首页> 外国专利> Isolated polynucleotide, methods for identifying or amplifying and genotyping all or part of a polynucleotide, for separating a polypeptide, to obtain an immunospecific antibody, for identifying an agent and a compound between one or more compounds to be tested, for analyzing the biological characteristics of a patient, to prevent or treat in an individual a disease and disorder or disease linked to the presence of polynucleotide in the genome, to increase or decrease activity in a polypeptide patient, to statistically determine relevant associations between at least one snp is a disease or disease resistance and for diagnosing or determining a disease prognosis or disease resistance, recombinant vector, host cell, polypeptide, immunospecific antibody, therapeutic agent, and compound

Isolated polynucleotide, methods for identifying or amplifying and genotyping all or part of a polynucleotide, for separating a polypeptide, to obtain an immunospecific antibody, for identifying an agent and a compound between one or more compounds to be tested, for analyzing the biological characteristics of a patient, to prevent or treat in an individual a disease and disorder or disease linked to the presence of polynucleotide in the genome, to increase or decrease activity in a polypeptide patient, to statistically determine relevant associations between at least one snp is a disease or disease resistance and for diagnosing or determining a disease prognosis or disease resistance, recombinant vector, host cell, polypeptide, immunospecific antibody, therapeutic agent, and compound

机译:分离的多核苷酸,鉴定或扩增和多核苷酸的全部或部分基因型,分离多肽,获得免疫特异性抗体,鉴定一种或多种待测化合物之间的试剂和化合物,分析其生物学特性的方法患者,以预防或治疗与基因组中多核苷酸的存在有关的疾病和病症或疾病,以增加或降低多肽患者的活性,以统计学方式确定至少一种snp是疾病或抗病性以及用于诊断或确定疾病预后或抗病性的重组载体,宿主细胞,多肽,免疫特异性抗体,治疗剂和化合物

摘要

"ISOLATED POLYNUCLEOTIDE, METHODS FOR IDENTIFYING OR AMPLIFYING AND FOR GENOTYPING ANY OR PART OF A POLYNUCLEOTIDE, TO SEPARATE AN IMMUNOSPECIFIC ANTIBODY, TO BE ANOTHER, COMPOSED AND AN AGENT, THE BIOLOGICAL CHARACTERISTICS OF A PATIENT, TO PREVENT OR TREAT IN AN INDIVIDUAL A DISEASE AND A DISEASE RELATED TO THE PRESENCE OF POLINUCLEOTIDE IN THE GENOME, TO INCREASE OR REDUCE THE ACTIVITY IN A PERSONALLY DEPENDENT PATIENT A PNS AND A DISEASE OR RESISTANCE TO THE DISEASE AND TO DIAGNOSED OR DETERMINED A PROGNOSIS OF A DISEASE OR A RESISTANCE TO A DISEASE, RECOMBINANT VECTOR, HOST CELL, COMPULATORY, ANTI-PHYSICAL, ANTIBODY, ANTICORPHERE The present invention relates to novel polynucleotides derived from the IFN? -17 gene nucleotide sequence comprising new SNPs and to novel polypeptides derived from the wild-type IFN? -17 protein comprising at least one mutation caused by the present invention. at least one SNP of the invention as well as its therapeutic uses.
机译:“分离的多核苷酸,鉴定或扩增多核苷酸的任何或一部分的方法,以分离出一种免疫特异性抗体,该另一种抗体是由患者组成的,由患者的生物学特性在患者中提供或治疗的。以及与基因组中多核苷酸的存在有关的疾病,以增加或减少PNS的相关患者的活动,以及对该疾病的疾病或抵抗力,以及对疾病或疾病的诊断或确定的预后重组载体,宿主细胞,计算,抗物理,抗体,抗癌肽本发明涉及衍生自包含新SNP的IFNα-17基因核苷酸序列的新型多核苷酸,并涉及衍生自野生型IFNα-17的新型多肽。包含至少一种由本发明引起的突变的蛋白质,至少一种本发明的SNP及其治疗用途。

著录项

  • 公开/公告号BR0209097A

    专利类型

  • 公开/公告日2005-04-19

    原文格式PDF

  • 申请/专利权人 GENODYSSEE;

    申请/专利号BR20020209097

  • 发明设计人 JEAN-LOUIS ESCARY;

    申请日2002-04-23

  • 分类号C12Q1/68;G01N33/68;C12N15/85;C12N15/63;C07K14/56;C07K16/00;C07K16/24;A61K38/21;A61P9/00;A61P31/12;A61P35/00;A61P37/00;

  • 国家 BR

  • 入库时间 2022-08-21 22:18:45

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号